Infermedica closes Series A funding with $10.25M

Photo of Piotr OrzechowskiPiotr Orzechowski
August 11, 2020
... min read

In the face of the COVID-19 pandemic, our mission of improving the quality of and access to primary care has become more relevant than ever. This is why we’re all proud to share that we've just completed a significant milestone in our company's journey.

Illustration by Tomek Tuz

With the participation of our existing investors - Karma Ventures, Inovo Venture Partners, and DreamIT Ventures, as well as two great new co-lead investors, EBRD and heal capital, we've just raised $10.25M Series A.

I'm honored to welcome our new partners on board, and I'm immensely grateful to our current investors for their continued support and faith in us. The new funds will help us grow into the next stage of our evolution focused on developing robust AI-based clinical decision support solutions for both patients and doctors.

Our values and amazing people

If you don't know us yet, Infermedica is a team of over 100 people - medical doctors, software engineers, and data scientists – who are passionate about the potential of artificial intelligence in preliminary medical diagnosis.

Every day we strive not only to deliver exceptional solutions supporting future-oriented healthcare organizations, but also to build an influential company culture based on three pillars:

  • Transparency – we stay honest and share our knowledge and experience with other

  • Outstanding support – our goal is to be the most supportive business partner ever, understanding our partners and delivering solutions that can genuinely answer their needs

  • Quality – we are constantly raising the bar to stand out in clinical safety, accuracy, quality of user experience and customer service

We believe that this approach allows us to create unique solutions enabling safe development of modern health care organizations. At the same time, these three values shape an internal environment that powers our team, and where terrific ideas are born.

At this point, I would like to express my deepest gratitude to the entire Infermedica team. You are a group of exceptional people, outstanding specialists in your fields, and your motivation, commitment, and experience allow us to fulfill our mission.

Where we are today

As of today our solutions have been used over 6 million times in 17 language versions. These results wouldn't have been possible without our clients and partners. We feel privileged to be trusted by over 50 world-class organizations such as Allianz Partners, Microsoft, Sana Kliniken, and Medis.

In the face of the coronavirus pandemic, we are especially conscious of the importance of our goal. We are also pleased with the internal projects that have been successfully implemented. This year, we decided to support healthcare systems, overburdened by the pandemic, with our COVID-19 Risk Assessment. Thanks to the Infermedica team's commitment, the tool was created in just three weeks and has been used by almost 300 organizations around the world, including two national governments.

On our way to the Virtual GP

We believe that in 5–10 years an FDA-approved chatbot combined with medical devices will be used to treat common health problems, significantly improving primary care physicians' everyday work. Our ultimate goal is to make primary care more accessible, accurate, and comfortable for everyone.

So far, our solutions have been focused on triaging patients and routing them to the most suitable point of care, thus saving time, unnecessary visits, and scarce clinical resources. Now, as the next step on the path to the "Virtual GP", we are working on clinical decision support capabilities such as automating mundane documentation tasks to save physicians time and providing them with rich and structured insights. We hope that in some time Infermedica will be smart enough to assist doctors in making the right decisions regarding diagnosis, treatment, and disease management, allowing every physician to perform at the top of their license.

Full steam ahead

The current investment round is another significant step ahead for our company. This additional funding will enable us to continue developing our technology and expanding our commercial operations, especially in the US and Germany.  Now we can move much faster, explore new paths and most importantly expand our amazing team.

I’m happy to say that we are actively looking for engineers, data scientists, programmers, and sales specialists. Right now, we have several open job positions, and we're adding new ones as we speak. Please reach out to us if you’d like to join our team.

On behalf of the entire company, I would like to thank everyone who supports us in our mission. From our users and clients, to our employees, investors and all enthusiasts out there – you give us the energy to move closer to our goal every single day.

Thank you!